Family Office
4BIO Capital
Singapore, Singapore
Type
Family Office
Check size
n/a
Verticals
advanced therapies, gene therapy, life sciences
Investment thesis
4BIO Capital is a London-based investment firm founded in 2018, specializing in advanced therapies and biotechnology. The company focuses on funding and supporting early-stage and growth-stage companies developing innovative treatments in areas such as gene therapy, cell therapy, RNA-based drugs, and targeted therapies. 4BIO Capital manages several funds and collaborates with academic institutions, research organizations, and industry partners to accelerate the development of transformative medical solutions. The firm is recognized for its expertise in the life sciences sector and its commitment to advancing next-generation therapeutics.
Partners
12 partners on file at this firm, with the firm's email pattern for cold outreach.
Partner names + email patterns are part of the deck-upload bundle. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 8,600+ others.
Score my deck → unlock contactsInvestment focus
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
UK, Europe, USA, APAC
Links
Want to know if 4BIO Capital is the right fit for your deck?
Drop your pitch deck. Claude scores it on the 8 dimensions VCs evaluate and tells you which of the 8,665 firms in our database are the best matches.
Score your deck (free, 30 seconds) →Similar investors
Family Office
North Point Securities
corporate finance, equity research, life sciences
Family Office
4Bio Capital
advanced therapies, life sciences, gene therapy
Family Office
SK Capital Partners
specialty materials, ingredients, life sciences
Family Office
Ventac Partners
biotech, life sciences, healthcare
Family Office
Gold Nest Capital
life sciences, healthcare, biotech